drugset / Trial / NCT05308732

Safety and Tolerability of the Use of Copaiba in Patients With Oral Cancer Submitted to Radiotherapy

NCT05308732 ↗

Phase 1 Active not recruiting 20 enrolled Brazilian National Cancer Institute
NaSequentialOpen-labelPrevention

Summary

This study aims to propose an alternative and auxiliary methodology for the prevention and treatment of Oral Mucositis (OM) in patients undergoing radiotherapy or radio and chemotherapy for head and neck neoplasms through the use of copaiba-based mouthwash, since the treatment that currently has proven efficacy for the prevention of OM(Low Power Laser Therapy) cannot be applied in tumor regions due to the risk of stimulating the tissue proliferation of malignant cells.

Timeline

Start
2021-05-11
Primary completion
2025-09-07
Completion
2026-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Copaiba Unknown 10 % Other
Subject Copaiba Unknown 15 % Other